logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
04/06/2025
Nasdaq index turned up, rising 0.2% most recently.
Latest
2 m ago
Hefeng Group: Wang Fengjiu pledged 6.6 million shares and released the pledge of 8.23 million shares.
2 m ago
MSCI global index reaches highest point since February.
3 m ago
Wan Tai Bioscience announced that its wholly-owned subsidiary Xiamen Wan Tai Canghai Biotechnology Co., Ltd. has obtained approval for the marketing of a nine-valent human papillomavirus vaccine (E. coli) (trade name: Xin Kenning 9). The vaccine is suitable for females aged 9-45, with a two-dose vaccination schedule for those aged 9-17 and a three-dose schedule for those aged 18-45. Prior to this, there was only one nine-valent HPV vaccine on the market globally, which was Merck's Gardasil 9. The approval of the marketing license application for the nine-valent HPV vaccine will benefit the promotion and use of the company's HPV vaccines, enrich the company's product line, and further enhance the company's core competitiveness, laying a solid foundation for the company's sustained and steady development.
3 m ago
Wan Tai Biological: Nine-valent HPV vaccine approved for market launch
5 m ago
In May, Tesla's sales soared in Australia, shining bright amid a gloomy global market.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.